Canton Strategic Holdings Inc (CNTN) Stock Score, Valuation & Financial Research

Canton Strategic Holdings Inc is in the Healthcare sector and Biotechnology industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. A complete Wall Street Score is not currently available.

Quick answer for CNTN

Canton Strategic Holdings Inc does not currently have a complete Wall Street Score. The stored market price is USD 2.34. These figures are a research snapshot, not a buy or sell recommendation.

What Canton Strategic Holdings Inc does

Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.

Company business and revenue

Research reporting period: 2025-12-31. A research update is not a new financial filing.

How the company makes money

Canton Strategic Holdings generates revenue primarily through a locking-as-a-service offering and network validation services. The company also maintains a digital asset treasury strategy, holding Canton Coin (CC) to support the digitization of traditional financial markets.

Products and services

  • Locking-as-a-service offerings and network validation services for the Canton Network.

Business relationships and partnerships

  • Canton Foundation — Strategic support partnership where the foundation supports the company's operations and digital asset strategy. Source

Business strengths to evaluate

  • First publicly traded company supported by the Canton Foundation Source

Business risks and research considerations

  • Risks associated with digital asset valuation and volatility of cryptocurrencies Source

Sources: Company research source · Canton Foundation

Company research refreshed 2026-10-12. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

CNTN financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:
Not currently available
Stored price:
USD 2.34
Market capitalization:
180.47M (currency not supplied)
Revenue:
USD 1.5M
Net income:
USD -98.12M
Free cash flow:
USD -93.7M
Cash:
USD 37.24M
Total debt:
USD 0.00
EPS:
USD -1.57

What stands out

  • Free cash flow is USD -93.7M, negative for the stored period.
  • The balance sheet shows USD 37.24M of cash versus USD 0.00 of total debt, an excess of cash over debt on these two reported measures.
  • The current research record carries a fundamental change risk warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

  • Free cash flow is -6264.0% of stored revenue. This is a simple cross-field ratio, not a verified same-period cash conversion margin; confirm reporting periods before comparison.
  • Net income equals -6559.3% of stored revenue. This is an indicative ratio only; accounting periods and units should be verified in filings.
  • Cash exceeds debt by USD 37.24M using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for CNTN

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

  • How long can CNTN fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • How is CNTN likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
  • What specifically needs to improve for CNTN to reach sustainable profitability?
  • What does the current fundamental change risk warning mean for the reliability or interpretation of CNTN's score?

What the numbers mean

A complete valuation score is not currently available, so valuation should be checked using the available earnings, cash-flow and price data.

A complete financial score is not currently available, so investors should review cash, debt, earnings and cash flow directly.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-01.

Research-input completeness: 64% of the scoring inputs required for this public page are currently available.

How to research CNTN

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.